Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-14 Purchase |
2023-08-16 4:31 pm |
PRECIGEN INC. | PGEN | Hassan Fred Director |
570,345 | $1.75 | $998,104 | 878,942 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
2,123 | $0 | $0 | 0 (Direct) |
View |
| 2021-12-29 Purchase |
2022-01-03 7:50 pm |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
19,300 | $14.17 | $273,390 | 19,300 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-13 Option Award |
2025-03-17 6:33 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
36,206 | $1.74 | 1,308,808 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-17 6:33 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
87,412 | $0 | 1,308,808 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-17 6:33 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
155,356 | $0 | 1,308,808 (Direct) |
View |
| 2025-01-03 Option Award |
2025-01-07 4:05 pm |
2026-01-03 2035-01-03 |
EyePoint Pharmaceuticals Inc. | EYPT | Hassan Fred Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-10-09 Option Award |
2024-10-11 4:05 pm |
N/A N/A |
Cocrystal Pharma Inc. | COCP | Hassan Fred Director |
8,067 | $0 | 1,023,296 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 4:02 pm |
N/A 2034-09-03 |
EyePoint Pharmaceuticals Inc. | EYPT | Hassan Fred Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:39 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-18 6:20 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
44,055 | $1.43 | 1,218,872 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-18 6:20 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
189,038 | $0 | 1,218,872 (Direct) |
View |
| 2024-03-09 Exercise |
2024-03-12 7:53 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
106,837 | $0 | 985,779 (Direct) |
View |
| 2023-07-18 Option Award |
2023-07-20 4:05 pm |
N/A 2033-07-18 |
Cocrystal Pharma Inc. | COCP | Hassan Fred Director |
7,333 | $0 | 7,333 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:19 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
51,501 | $0 | 51,501 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 5:39 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
2,123 | $0 | 2,123 (Direct) |
View |
Ownership |
2023-04-27 4:01 pm |
N/A N/A |
Cocrystal Pharma Inc. | COCP | Hassan Fred Director |
0 | $0 | 1,015,229 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-13 5:02 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
48,290 | $1.17 | 540,923 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-13 5:02 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
232,326 | $0 | 540,923 (Direct) |
View |
| 2023-02-22 Exercise |
2023-02-24 8:09 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
61,576 | $0 | 260,307 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:29 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 7:20 pm |
N/A 2032-05-18 |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
21,013 | $0 | 21,013 (Direct) |
View |
| 2022-03-25 Exercise |
2022-03-29 5:04 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
16,212 | $0 | 198,731 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:48 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
27,832 | $2.03 | 327,284 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:48 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
144,765 | $0 | 327,284 (Direct) |
View |
| 2021-11-14 Option Award |
2021-11-16 9:19 pm |
N/A 2031-11-13 |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
541 | $0 | 541 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-26 5:14 pm |
N/A 2031-08-16 |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
49,869 | $0 | 49,869 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-17 7:24 pm |
N/A 2031-05-13 |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 7:46 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
7,328 | $7.71 | 193,006 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 7:46 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
38,319 | $0 | 193,006 (Direct) |
View |
| 2021-03-13 Exercise |
2021-03-16 4:35 pm |
N/A N/A |
PRECIGEN INC. | PGEN | Hassan Fred Director |
62,189 | $0 | 147,359 (Direct) |
View |
| 2020-05-05 Option Award |
2020-05-07 8:40 pm |
N/A N/A |
AMGEN INC | AMGN | Hassan Fred Director |
846 | $0 | 9,191 (Direct) |
View |